Hairy Cell Leukemia - 25 Studies Found

Completed : A Phase I, Multicenter Dose Escalation Study in Patients With Leukemia
: Hairy Cell Leukemia
: 2007-12-21
: Biological: CAT 8015 (Moxetumomab Pasudotox) The dose level of the initial cohort will be 5 μg/kg s
Completed : BL22 Immunotoxin in Treating Patients Previously Treated With Cladribine for Hairy Cell Leukemia
: Leukemia
: 2003-12-10
: Drug: BL22 Dosing via IV on Days 1,3, and 5.
Completed : Analysis of Blood and Bone Marrow to Detect Residual Disease in Patients With Previously Treated Hairy Cell Leukemia
: Leukemia
: 2000-05-02
:
  • Genetic: polymerase chain reaction
  • Other:

Completed : Rituximab in Treating Patients With Refractory or Recurrent Hairy Cell Leukemia Following Cladribine Therapy
: Leukemia
: 1999-11-01
: Biological: rituximab
Completed : Daily or Weekly Cladribine in Treating Patients With Hairy Cell Leukemia
: Leukemia
: 1999-11-01
:
  • Drug: 2-chlorodeoxyadenosine (CDA) daily

Recruiting : 2CDA With Rituximab in Hairy Cell Leukemia
: Leukemia
: 2006-12-14
:
  • Drug: Cladribine 5.6 mg/m^2 by
Recruiting : Safety Study of CAT-8015 Immunooxin in Patients With HCL With Advance Disease
:
  • Leukemia
  • Hairy Cell Leukemia

  • : 2007-04-16
    :
    • Drug: Immunotoxin therapy
    • Drug: CAT-8015 I
Active, not recruiting : Moxetumomab Pasudotox for Advanced Hairy Cell Leukemia
: Leukemia, Hairy Cell
: 2013-04-09
:
  • Drug: moxetumomab pasudotox
  • Drug: IV Bag P
Recruiting : Clinical Research in Hairy Cell Leukemia:Surveillance and Documentation of Clinical Outcomes
: Leukemia, Other
: 2015-08-20
Recruiting : Assessment of the V600E Mutation in the B-RAF Gene in Chronic Lymphoproliferative Disease
:
  • Hairy Cell Leukemia
  • Splenic Marginal Zone Lymphoma

: 2012-10-31
<<< Previous | Next >>>